Equitable Trust Co. Purchases 2,271 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Equitable Trust Co. raised its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 47.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,096 shares of the company's stock after acquiring an additional 2,271 shares during the period. Equitable Trust Co.'s holdings in Addus HomeCare were worth $889,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Quarry LP bought a new stake in Addus HomeCare during the 3rd quarter worth approximately $28,000. Farther Finance Advisors LLC grew its position in Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock worth $49,000 after acquiring an additional 366 shares during the last quarter. KBC Group NV grew its position in Addus HomeCare by 49.1% during the 4th quarter. KBC Group NV now owns 814 shares of the company's stock worth $102,000 after acquiring an additional 268 shares during the last quarter. GAMMA Investing LLC grew its position in Addus HomeCare by 25.7% during the 3rd quarter. GAMMA Investing LLC now owns 935 shares of the company's stock worth $124,000 after acquiring an additional 191 shares during the last quarter. Finally, Assetmark Inc. grew its position in Addus HomeCare by 11.5% during the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company's stock worth $156,000 after acquiring an additional 121 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms recently commented on ADUS. Citizens Jmp upgraded Addus HomeCare to a "strong-buy" rating in a research report on Monday, December 16th. Macquarie reiterated an "outperform" rating and issued a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. Royal Bank of Canada reiterated an "outperform" rating and issued a $136.00 price objective on shares of Addus HomeCare in a research report on Thursday, November 14th. Oppenheimer increased their price objective on Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Finally, StockNews.com upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of $134.22.

Addus HomeCare Price Performance

Shares of ADUS stock traded down $2.27 during trading hours on Friday, reaching $113.22. The company had a trading volume of 148,955 shares, compared to its average volume of 163,305. The company has a 50 day moving average of $126.04 and a 200 day moving average of $127.04. The firm has a market cap of $2.05 billion, a price-to-earnings ratio of 25.91, a P/E/G ratio of 1.55 and a beta of 1.00. Addus HomeCare Co. has a 1-year low of $85.94 and a 1-year high of $136.72.

Insider Activity

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. This represents a 18.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the transaction, the chief executive officer now owns 79,397 shares of the company's stock, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 39,750 shares of company stock valued at $4,930,750 in the last 90 days. 4.60% of the stock is owned by company insiders.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.